TNNI3 and cardiomyopathy: Indeed, high-sensitivity cardiac troponin I (hs-cTnI) serves as a biomarker and the gold standard for detecting myocardial injury and MI in patients, but this has less sensitivity for detecting cardiomyopathies (28).